NOTICE REGARDING THE AVAILABILITY OF ADMINISTRATIVE SUPPLEMENTS TO SUPPORT STUDY OF DRUG ABUSE AND CO-OCCURRING INFECTIONS INCLUDING HIV, OTHER BLOOD- BORNE AND SEXUALLY-TRANSMITTED INFECTIONS Release Date: March 11, 2002 NOTICE: NOT-DA-02-005 National Institute on Drug Abuse (NIDA) (www.nida.nih.gov) PURPOSE The National Institute on Drug Abuse (NIDA) announces the availability of funds to administratively supplement existing NIDA-supported research projects (within the scope of the original grant) to study drugs of abuse and co-occurring infections including HIV and other blood-borne and sexually transmitted infections. Funds will be provided through administrative supplements to take advantage of unique opportunities to support research in all areas of drug-abuse and HIV/AIDS science. Only existing R01 and R21 grants supported by NIDA with at least one year of support remaining at the time of the supplemental award are eligible for supplemental support under this notice. Supplements may be requested for up to 2 years of support, but extend no longer than the parent grant, with funding beginning no later than September 30, 2002. For more information refer to http://www.drugabuse.gov/Funding/AIDSSupplement.html. INQUIRIES Inquiries concerning this notice are strongly encouraged. The opportunity to clarify any issue or questions from potential applicants is welcome. o Direct any questions about this notice to: Sander Genser, M.D., M.P.H., or Jag H. Khalsa, Ph.D. Center on AIDS and Other Medical Consequences of Drug Abuse National Institute on Drug Abuse 6001 Executive Boulevard, Room 5198, MSC 9593 Bethesda, MD 20892-9581 Telephone: (301) 443-1801 E-mail: sg73f@nih.gov or jk98p@nih.gov
Return to NIH Guide Main Index
Office of Extramural Research (OER) |
National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892 |
Department of Health and Human Services (HHS) |
||||||||
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, RealPlayer, Video or Flash files, see Help Downloading Files. |